79.71 USD
+0.93 (+1.18%)
Last: Feb 4, 2026, 01:46 PM
ChartMill assigns a Buy % Consensus number of 79% to GEHC. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 93.55. This target is 17.36% above the current price.
- GEHC was analyzed by 28 analysts. The buy percentage consensus is at 79. So analysts seem to be have mildly positive about GEHC.
- In the previous month the buy percentage consensus was at a similar level.
- GEHC was analyzed by 28 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-01-30 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2026-01-15 | UBS | Downgrade | Neutral -> Sell |
| 2026-01-07 | Stifel | Maintains | Buy -> Buy |
| 2026-01-05 | B of A Securities | Maintains | Neutral -> Neutral |
| 2025-12-11 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-12-11 | Jefferies | Maintains | Buy -> Buy |
| 2025-11-21 | BTIG | Reiterate | Buy -> Buy |
| 2025-10-30 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-10-30 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-10-30 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-10-13 | BTIG | Maintains | Buy -> Buy |
| 2025-10-13 | Barclays | Initiate | Equal-Weight |
| 2025-10-07 | Citigroup | Downgrade | Buy -> Neutral |
| 2025-07-31 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-07-31 | Citigroup | Maintains | Buy -> Buy |
| 2025-07-09 | Citigroup | Maintains | Buy -> Buy |
| 2025-05-06 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-05-05 | UBS | Upgrade | Sell -> Neutral |
| 2025-05-01 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-05-01 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-05-01 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-04-30 | Citigroup | Maintains | Buy -> Buy |
| 2025-04-23 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-03-11 | Goldman Sachs | Upgrade | Neutral -> Buy |
| 2025-02-14 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-02-13 | Citigroup | Maintains | Buy -> Buy |
| 2025-01-08 | Jefferies | Upgrade | Hold -> Buy |
| 2024-10-31 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-10-01 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2024-09-30 | Stifel | Maintains | Buy -> Buy |
GE HEALTHCARE TECHNOLOGY / GEHC FAQ
Can you provide the average price target for GE HEALTHCARE TECHNOLOGY stock?
28 analysts have analysed GEHC and the average price target is 93.55 USD. This implies a price increase of 17.36% is expected in the next year compared to the current price of 79.71.
What is the consensus rating for GEHC stock?
The consensus rating for GE HEALTHCARE TECHNOLOGY (GEHC) is 79.2857 / 100 . This indicates that analysts generally have a positive outlook on the stock.